These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
7. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles. Ogletree ML; Allen GT J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361 [TBL] [Abstract][Full Text] [Related]
8. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
9. Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains. Misra RN; Brown BR; Han WC; Harris DN; Hedberg A; Webb ML; Hall SE J Med Chem; 1991 Sep; 34(9):2882-91. PubMed ID: 1910091 [TBL] [Abstract][Full Text] [Related]
10. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation]. Kakushi H; Shike T; Uchida K Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807 [TBL] [Abstract][Full Text] [Related]
11. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612 [TBL] [Abstract][Full Text] [Related]
12. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo. Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979 [TBL] [Abstract][Full Text] [Related]
13. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids. Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586 [TBL] [Abstract][Full Text] [Related]
14. Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pigs. Arimura A; Asanuma F; Kurosawa A; Harada M Int Arch Allergy Immunol; 1992; 98(3):239-46. PubMed ID: 1392626 [TBL] [Abstract][Full Text] [Related]
16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]